Clinical Trials Directory

Trials / Conditions / Hemolytic Anemia

Hemolytic Anemia

10 registered clinical trials studyying Hemolytic Anemia — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedInvestigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects
NCT07040787
Chengdu Suncadia Medicine Co., Ltd.Phase 1
Not Yet RecruitingStudy of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728
Sohag University—
CompletedA Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in H
NCT06684041
Chengdu Suncadia Medicine Co., Ltd.Phase 1
CompletedThe Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
NCT05004259
Dartmouth-Hitchcock Medical CenterPhase 1
Active Not RecruitingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With St
NCT04610866
National Heart, Lung, and Blood Institute (NHLBI)Phase 1 / Phase 2
CompletedImmunoglobulin Dosage and Administration Form in CIDP and MMN
NCT02111590
Rigshospitalet, Denmark—
CompletedDemographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
NCT00971984
HaEmek Medical Center, Israel—
CompletedLong Term Effects of Erythrocyte Lysis
NCT00842621
St. Jude Children's Research Hospital—
CompletedStudy of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
NCT00110617
Novartis PharmaceuticalsPhase 2
CompletedCombination Drug Therapy for Patients With Hepatitis C
NCT00001729
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 3